These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12231529)

  • 21. Mutant thyroid hormone receptor beta represses the expression and transcriptional activity of peroxisome proliferator-activated receptor gamma during thyroid carcinogenesis.
    Ying H; Suzuki H; Zhao L; Willingham MC; Meltzer P; Cheng SY
    Cancer Res; 2003 Sep; 63(17):5274-80. PubMed ID: 14500358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
    Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
    Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma.
    Machens A; Holzhausen HJ; Dralle H
    Cancer; 2005 Jun; 103(11):2269-73. PubMed ID: 15856429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Transfection of follicular thyroid gland carcinoma cells with human TSH receptor changes growth, invasion and adhesion].
    Hoelting T; Duh QY; Clark OH; Herfarth C
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):281-4. PubMed ID: 14518260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial DNA alterations in thyroid cancer.
    Tong BC; Ha PK; Dhir K; Xing M; Westra WH; Sidransky D; Califano JA
    J Surg Oncol; 2003 Mar; 82(3):170-3. PubMed ID: 12619060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
    Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
    Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas.
    Castellone MD; Guarino V; De Falco V; Carlomagno F; Basolo F; Faviana P; Kruhoffer M; Orntoft T; Russell JP; Rothstein JL; Fusco A; Santoro M; Melillo RM
    Oncogene; 2004 Aug; 23(35):5958-67. PubMed ID: 15184868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial non-medullary thyroid cancer: a matched-case control study.
    Maxwell EL; Hall FT; Freeman JL
    Laryngoscope; 2004 Dec; 114(12):2182-6. PubMed ID: 15564841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
    Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follicular thyroid cancer cells: a model of metastatic tumor in vitro (review).
    Hoelting T; Goretzki PE; Duh QY
    Oncol Rep; 2001; 8(1):3-8. PubMed ID: 11115561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population-based outcomes for pediatric thyroid carcinoma.
    Shapiro NL; Bhattacharyya N
    Laryngoscope; 2005 Feb; 115(2):337-40. PubMed ID: 15689762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
    McCaffrey JC
    Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease?
    Londero SC; Godballe C; Krogdahl A; Bastholt L; Specht L; Sørensen CH; Pedersen HB; Pedersen U; Christiansen P
    Acta Oncol; 2008; 47(3):451-7. PubMed ID: 17906980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical study of glypican 3 in thyroid cancer.
    Yamanaka K; Ito Y; Okuyama N; Noda K; Matsumoto H; Yoshida H; Miyauchi A; Capurro M; Filmus J; Miyoshi E
    Oncology; 2007; 73(5-6):389-94. PubMed ID: 18511877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anatomo-pathology and histological prognosis of follicular thyroid carcinoma].
    de Micco C
    Ann Endocrinol (Paris); 1997; 58(3):172-82. PubMed ID: 9239238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infrequent microsatellite instability in papillary carcinomas of the thyroid.
    Yamamoto T
    Hiroshima J Med Sci; 1999 Sep; 48(3):95-8. PubMed ID: 10598412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of YAP1 in aggressive thyroid cancer.
    Celano M; Mignogna C; Rosignolo F; Sponziello M; Iannone M; Lepore SM; Lombardo GE; Maggisano V; Verrienti A; Bulotta S; Durante C; Di Loreto C; Damante G; Russo D
    Endocrine; 2018 Jan; 59(1):209-212. PubMed ID: 28120182
    [No Abstract]   [Full Text] [Related]  

  • 38. Instability of microsatellites in radiation-associated thyroid tumours with short latency periods.
    Lohrer HD; Braselmann H; Richter HE; Jackl G; Herbeck J; Hieber L; Kellerer AM; Bauchinger M
    Int J Radiat Biol; 2001 Aug; 77(8):891-9. PubMed ID: 11571023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testosterone regulates thyroid cancer progression by modifying tumor suppressor genes and tumor immunity.
    Zhang LJ; Xiong Y; Nilubol N; He M; Bommareddi S; Zhu X; Jia L; Xiao Z; Park JW; Xu X; Patel D; Willingham MC; Cheng SY; Kebebew E
    Carcinogenesis; 2015 Apr; 36(4):420-8. PubMed ID: 25576159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors in thyroid carcinoma.
    Treseler PA; Clark OH
    Surg Oncol Clin N Am; 1997 Jul; 6(3):555-98. PubMed ID: 9210356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.